HIV-1 infection induces a strong and chronic Bortezomib purchase over-activation of the CD8 T cell compartment, measured by the expression of CD38, a glycoprotein present on immature T and B lymphocytes, lost on mature cells and re-expressed during cell activation and acute viral infection [1, 2]. Highly active antiretroviral therapy (HAART), the standard care in paediatric and adult HIV-infected population, leads to virus suppression associated with decreased CD38 expression, increased CD4 T cell counts, recovery of immune function against opportunistic infections and
a good clinical outcome in the majority of patients [3–6]. Undetectable viral load can be achieved in all patients, but this aim is more difficult in children probably due to the characteristic of their immature immune system, poor adherence and availability of new antiretrovirals [4–7]. Moreover, some patients may show incomplete suppression (>50 HIV RNA copies/ml) with a restored CD4 T cell population (>25% of total lymphocytes) (virological discordant response) or undetectable BMS-354825 manufacturer viral load (<50 copies/ml) with scanty CD4 recovery (immunological discordant response). In these patients, CD38 expression on CD8 T cells may provide information
about residual immune activation, while in vitro lymphocyte proliferation, one of the oldest and most widely applied methods for detecting impaired T cell function [8], may describe functional immuno-competence of the restored CD4 population identifying subjects at risk for opportunistic infections [9–14]. Although CD4 percentage and count is a validated surrogate marker of immune competence, the functional evaluation of the CD4 memory T cell proliferation to opportunistic pathogens Rebamipide is reckoned more specific for diagnosing infection susceptibility as compared to response to mitogens, potent stimulators of T cells activation and proliferation regardless of their
antigen specificity. There is evidence that CD38 expression negatively correlates with CD4 cell counts [15, 16] and with CD4 central memory reconstitution in virally suppressed HIV-1-infected adults [17], suggesting that CD38 activation may augment our ability to determine whether therapy has an impact on CD4 recovery. We were interested to study whether the combination of traditional assays (viral load and CD4 T cell immunophenotyping) with the measure of CD38 activation and CD4 T cell function could classify children with a discordant immuno-virological response to HAART more accurately. We performed a retrospective study to establish the diagnostic utility of CD38 expression on CD8 T lymphocytes, for discriminating responders versus non-responders defined on the basis of traditional viral load and CD4 T cell count criteria.